vix.ing · top · new · best · stats · spec

Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital

2026/01/01 by Jennifer Ross, Kimberly Boeser, Matthew Hordyk +6 · 1 voice
Economics, Econometrics and Finance · Immunology and Microbiology · Medicine · #Antibiotic Use and Resistance #Antibiotics Pharmacokinetics and Efficacy #Health Systems, Economic Evaluations, Quality of Life

paper · pdf · doi:10.1017/ash.2026.10329

openalex publication_date 2026/01/01 · openalex created_date 2026/04/02 · openalex updated_date 2026/07/27

Abstract

We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.

Citations

Discussions

Related